Table 2.
Multivariable models
| Variable | DM | PCSM | OS | |||
|---|---|---|---|---|---|---|
| Hazard Ratio (95% CI), P-value | ||||||
|
| ||||||
| GC score | 1.22 (1.09 - 1.36) | <0.001* | 1.23 (1.09 - 1.39) | <0.001* | 1.12 (1.05 - 1.20) | 0.001* |
| Age | 1.00 (0.96 - 1.04) | 0.98 | 1.00 (0.96 - 1.04) | 0.97 | 1.07 (1.04 - 1.10) | <0.001* |
| Log2 pre-treatment PSA | 0.99 (0.80 - 1.22) | 0.91 | 0.96 (0.78 - 1.18) | 0.68 | 1.01 (0.88 - 1.15) | 0.90 |
| T3-T4 vs. T1-T2 | 1.52 (0.89 - 2.62) | 0.13 | 1.40 (0.80 - 2.43) | 0.24 | 1.19 (0.85 - 1.67) | 0.30 |
| Gleason 8-10 vs. <8 | 2.46 (1.41 – 4.31) | 0.002* | 1.31 (0.73 – 2.36) | 0.36 | 1.40 (0.99 – 1.99) | 0.06 |
Hazard ratios of genomic classifiers were per 0.1 unit increased. Strata = original arm. Death as a competing risk for DM and PCSM.